Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKenna, R. J.
Right arrow Articles by McMurtrey, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKenna, R. J., Jr
Right arrow Articles by McMurtrey, M. J.

Chest, Vol 86, 671-674, Copyright © 1984 by American College of Chest Physicians

ARTICLES

Open lung biopsy in immunocompromised patients

RJ McKenna Jr, CF Mountain and MJ McMurtrey

Increased use of open lung biopsy in the search for a treatable etiology of acute interstitial pneumonitis (AIP) in immunocompromised patients is based on the assumption that examination and cultures from biopsy specimens will yield significant information leading to beneficial treatment of the condition. To assess the true impact of the results of open lung biopsy on the subsequent treatment and outcome in such patients, a retrospective study was done of 64 consecutive patients undergoing the procedure in a recent five-year period. When open lung biopsy was performed for the diagnosis of AIP in immunocompromised patients after empiric broad spectrum treatment failed, it rarely missed a specific, treatable etiology, if present. However, the results from open lung biopsy infrequently lead to a change in the treatment that improves the patient's clinical course.


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
J.-Y. Wang, Y.-L. Chang, L.-N. Lee, J.-H. Chen, J.-L. Tang, P.-C. Yang, and Y.-C. Lee
Diffuse pulmonary infiltrates after bone marrow transplantation: the role of open lung biopsy
Ann. Thorac. Surg., July 1, 2004; 78(1): 267 - 272.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A T Jones, R M Du Bois, and A U Wells
The pulmonary physician in critical care * Illustrative case 2: Interstitial lung disease
Thorax, April 1, 2003; 58(4): 361 - 364.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. A. WHITE, P. W. WONG, and R. DOWNEY
The Utility of Open Lung Biopsy in Patients with Hematologic Malignancies
Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 723 - 729.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Chest Physicians.